Your browser doesn't support javascript.
loading
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.
Naipauer, Julian; Rosario, Santas; Gupta, Sachin; Premer, Courtney; Méndez-Solís, Omayra; Schlesinger, Mariana; Ponzinibbio, Virginia; Jain, Vaibhav; Gay, Lauren; Renne, Rolf; Chan, Ho Lam; Morey, Lluis; Salyakina, Daria; Abba, Martin; Williams, Sion; Hare, Joshua M; Goldschmidt-Clermont, Pascal J; Mesri, Enrique A.
Afiliação
  • Naipauer J; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Rosario S; UM-CFAR/ Sylvester CCC Argentina Consortium for Research and Training in Virally induced AIDS-Malignancies, Miami, Florida, United States of America.
  • Gupta S; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Premer C; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Méndez-Solís O; Interdisciplinary Stem Cell Institute; University of Miami Miller School of Medicine, Miami, Florida, United States of America.
  • Schlesinger M; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Ponzinibbio V; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Jain V; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Gay L; UM-CFAR/ Sylvester CCC Argentina Consortium for Research and Training in Virally induced AIDS-Malignancies, Miami, Florida, United States of America.
  • Renne R; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
  • Chan HL; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
  • Morey L; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
  • Salyakina D; Department of Human Genetics, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida, United States of America.
  • Abba M; Department of Human Genetics, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida, United States of America.
  • Williams S; Tumor Biology Program, Sylvester Comprehensive Cancer Center and Miami Center for AIDS Research, Department of Microbiology and Immunology, Miami, Florida, United States of America.
  • Hare JM; UM-CFAR/ Sylvester CCC Argentina Consortium for Research and Training in Virally induced AIDS-Malignancies, Miami, Florida, United States of America.
  • Goldschmidt-Clermont PJ; Centro de Investigaciones Inmunológicas Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.
  • Mesri EA; UM-CFAR/ Sylvester CCC Argentina Consortium for Research and Training in Virally induced AIDS-Malignancies, Miami, Florida, United States of America.
PLoS Pathog ; 15(12): e1008221, 2019 12.
Article em En | MEDLINE | ID: mdl-31881074
Kaposi's sarcoma (KS) is an AIDS-defining cancer caused by the KS-associated herpesvirus (KSHV). Unanswered questions regarding KS are its cellular ontology and the conditions conducive to viral oncogenesis. We identify PDGFRA(+)/SCA-1(+) bone marrow-derived mesenchymal stem cells (Pα(+)S MSCs) as KS spindle-cell progenitors and found that pro-angiogenic environmental conditions typical of KS are critical for KSHV sarcomagenesis. This is because growth in KS-like conditions generates a de-repressed KSHV epigenome allowing oncogenic KSHV gene expression in infected Pα(+)S MSCs. Furthermore, these growth conditions allow KSHV-infected Pα(+)S MSCs to overcome KSHV-driven oncogene-induced senescence and cell cycle arrest via a PDGFRA-signaling mechanism; thus identifying PDGFRA not only as a phenotypic determinant for KS-progenitors but also as a critical enabler for viral oncogenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Receptor alfa de Fator de Crescimento Derivado de Plaquetas / Células-Tronco Mesenquimais / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Receptor alfa de Fator de Crescimento Derivado de Plaquetas / Células-Tronco Mesenquimais / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos